Author Information
Dr. Stephen Bruce Baylin is a prominent researcher affiliated with The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and The Johns Hopkins University School of Medicine in Baltimore, MD, USA. Additionally, he is associated with the Center for Epigenetics at the Van Andel Research Institute in Grand Rapids, MI, USA. His work primarily focuses on the field of cancer research, with a strong emphasis on epigenetics and molecular biology.Research Contributions
Dr. Baylin has made significant contributions to the understanding of cancer and viral infections, particularly in the context of epigenetics and molecular biology. His recent publications include studies on the downregulation of mitochondrial genes during SARS-CoV-2 infection, the interplay between lncRNAs, RNA-binding proteins, and viral genomes, and clinical trials involving DNA methyltransferase inhibitors and PARP inhibitors in leukemia. His research also covers the clinical significance of plasma exosomes in lung cancer patients with HIV, the role of bacterial-driven inflammation in colon tumorigenesis, and the discovery of first-in-class reversible DNMT1-selective inhibitors for leukemia. Dr. Baylin's work has been instrumental in advancing therapeutic strategies for various cancers and viral infections.Aliases
Dr. Stephen Bruce Baylin is known by several aliases, including S B Baylin, Steven Baylin, Stephen B Baylin, Stephen B. Baylin, S. B. Baylin, Steve B. Baylin, S. Baylin, and Steve Baylin.Publication and Citation Metrics
| Metric |
Value |
| Total Citations |
188,195 |
| h-index |
170 |
| Total Papers |
638 |
